Articles tagged with “biopharma-m-a”

2026 Biotech Capital Outlook: Blackstone's $6.3B Fund VI

Analyze the 2026 biotech capital outlook, detailing Blackstone's record $6.3B Life Sciences Fund VI, VC funding trends, biopharma M&A, and market recovery.

80 min read

4/26/2026

biotech capital outlook blackstone life sciences biotech funding 2026 biopharma m&a life sciences investment venture capital biotech ipo trends

Biopharma M&A Q1 2026: Deal Tracker and AI Valuations

Analyze Q1 2026 biopharma M&A trends, including 19 billion-dollar deals. Learn how patent cliffs and AI valuation drivers impact pharmaceutical acquisitions.

30 min read

4/22/2026

biopharma m&a biotech valuations ai drug discovery patent cliffs pharmaceutical acquisitions healthcare finance deal tracker

Biopharma M&A IT Integration: Consolidating GxP Systems

Analyze IT integration in biopharma M&A. This report explains strategies for consolidating GxP systems, ensuring compliance, and capturing cost synergies.

70 min read

3/3/2026

biopharma m&a it integration gxp systems post-merger integration system consolidation regulatory compliance pharma due diligence